SCHEMBL3661626

SCHEMBL3661626

COc1c(C(=O)NCc2cc3cccc(Cl)c3nc2-c2ccccc2)ccnc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.45
CASR P41180 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
APEX1 P27695 2/20 0.41
NPC1 O15118 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPK8 P45983 2/20 0.40
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39
DGAT2 Q96PD7 3/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1313712 0.76 PIK3CD (0.49) PIK3CDSMN1; SMN2CYP1A2CYP3A4CYP2D6
SCHEMBL4178662 0.72 PIK3CD (0.47) PIK3CDSMN1; SMN2APEX1MAPTMAPK8
SCHEMBL14047548 0.72 PIK3CD (0.45) PIK3CDSMN1; SMN2NPC1CYP1A2CYP3A4
SCHEMBL19413117 0.70 DHODH (0.46) PIK3CDTP53
SCHEMBL1880602 0.68 DHODH (0.46) PIK3CDCYP1A2CYP3A4TP53MEN1
SCHEMBL716341 0.66 L3MBTL1 (0.50) PIK3CDSMN1; SMN2NPC1CYP1A2CYP3A4
SCHEMBL29554697 0.66 DHODH (0.50) CYP1A2CYP2C19LMNATP53MEN1
SCHEMBL1313748 0.66 PNMT (0.42) PIK3CDSMN1; SMN2CYP3A4LMNA
SCHEMBL4177662 0.65 BDKRB1 (0.43) PIK3CDLMNAMEN1KMT2A
SCHEMBL17813592 0.64 LMNA (0.50) SMN1; SMN2APEX1MAPTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139882-A1 3- SUBSTITUTED QUINOLINE OR QUINOXALINE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE ( PI3K) INHIBITORS Amgen Inc. (US) 2010-01-06 EP disclosed
WO-2008118455-A1 δ3- SUBSTITUTED QUINOLINE OR QUINOXALINE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE ( PI3K) INHIBITORS AMGEN INC. (US) 2008-10-02 WO disclosed